Quinn Opportunity Partners LLC Cure Vac N.V. Transaction History
Quinn Opportunity Partners LLC
- $939 Million
- Q3 2024
A detailed history of Quinn Opportunity Partners LLC transactions in Cure Vac N.V. stock. As of the latest transaction made, Quinn Opportunity Partners LLC holds 30,000 shares of CVAC stock, worth $88,800. This represents 0.01% of its overall portfolio holdings.
Number of Shares
30,000
Previous 30,000
-0.0%
Holding current value
$88,800
Previous $102,000
13.73%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding CVAC
# of Institutions
93Shares Held
12.3MCall Options Held
164KPut Options Held
117K-
Israel Englander Millennium Management LLC | New York, Ny2.42MShares$7.16 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.25MShares$6.67 Million0.0% of portfolio
-
Bill & Melinda Gates Foundation Seattle, WA1.57MShares$4.64 Million10.6% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.01MShares$2.99 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct780KShares$2.31 Million0.01% of portfolio
About CureVac N.V.
- Ticker CVAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,467,008
- Market Cap $555M
- Description
- CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...